Moderators of effects of motivational enhancements to cognitive behavioral therapy. 2005

Andrew Rosenblum, and Jeffrey Foote, and Charles Cleland, and Stephen Magura, and Daneyal Mahmood, and Nicole Kosanke
Institute for Treatment and Services Research, National Development and Research Institutes, Inc, New York, New York 10048, USA. rosenblum@ndri.org

Patient treatment matching hypotheses were tested for substance users randomly assigned to a group cognitive behavioral therapy (CBT; n= 114) or a group motivational intervention (GMI; n= 116). Treatment was scheduled twice weekly for 10 weeks. Using a patient attribute by treatment interaction design with a 15-week follow-up, the study predicted that alexithymia, antisocial personality disorder (ASPD), and network support for alcohol and drug use would be associated with less substance use for CBT subjects and that hostility and lower treatment motivation would be associated with less substance use for GMI subjects. Three of the hypothesized moderators were empirically supported: alexithymia, network support for alcohol, and ASPD. Results indicate the use of assessing specific patient attributes to better inform treatment recommendations.

UI MeSH Term Description Entries
D008297 Male Males
D009042 Motivation Those factors which cause an organism to behave or act in either a goal-seeking or satisfying manner. They may be influenced by physiological drives or by external stimuli. Incentives,Disincentives,Expectations,Disincentive,Expectation,Incentive,Motivations
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005260 Female Females
D006197 Hair A filament-like structure consisting of a shaft which projects to the surface of the SKIN from a root which is softer than the shaft and lodges in the cavity of a HAIR FOLLICLE. It is found on most surfaces of the body. Fetal Hair,Hair, Fetal,Lanugo,Fetal Hairs,Hairs,Hairs, Fetal
D006791 Hostility Tendency to feel anger toward and to seek to inflict harm upon a person or group. Hostilities
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000342 Affective Symptoms Mood or emotional responses dissonant with or inappropriate to the behavior and/or stimulus. Alexithymia,Emotional Disturbances,Affective Symptom,Alexithymias,Disturbance, Emotional,Disturbances, Emotional,Emotional Disturbance,Symptom, Affective,Symptoms, Affective
D000987 Antisocial Personality Disorder A personality disorder whose essential feature is a pervasive pattern of disregard for, and violation of, the rights of others that begins in childhood or early adolescence and continues into adulthood. The individual must be at least age 18 and must have a history of some symptoms of CONDUCT DISORDER before age 15. (From DSM-IV, 1994). Antisocial Behavior,Deviant Behavior,Dyssocial Behavior,Personality Disorder, Antisocial,Psychopathic Personality,Sociopathic Personality,Antisocial Personality,Antisocial Behaviors,Antisocial Personalities,Antisocial Personality Disorders,Behavior, Antisocial,Behavior, Deviant,Behavior, Dyssocial,Behaviors, Antisocial,Behaviors, Deviant,Behaviors, Dyssocial,Deviant Behaviors,Disorder, Antisocial Personality,Disorders, Antisocial Personality,Dyssocial Behaviors,Personalities, Antisocial,Personalities, Psychopathic,Personalities, Sociopathic,Personality Disorders, Antisocial,Personality, Antisocial,Personality, Psychopathic,Personality, Sociopathic,Psychopathic Personalities,Sociopathic Personalities

Related Publications

Andrew Rosenblum, and Jeffrey Foote, and Charles Cleland, and Stephen Magura, and Daneyal Mahmood, and Nicole Kosanke
October 2016, Child and adolescent psychiatric clinics of North America,
Andrew Rosenblum, and Jeffrey Foote, and Charles Cleland, and Stephen Magura, and Daneyal Mahmood, and Nicole Kosanke
June 2008, Drug and alcohol dependence,
Andrew Rosenblum, and Jeffrey Foote, and Charles Cleland, and Stephen Magura, and Daneyal Mahmood, and Nicole Kosanke
June 2013, Journal of the American Psychoanalytic Association,
Andrew Rosenblum, and Jeffrey Foote, and Charles Cleland, and Stephen Magura, and Daneyal Mahmood, and Nicole Kosanke
January 2016, Journal of clinical psychology,
Andrew Rosenblum, and Jeffrey Foote, and Charles Cleland, and Stephen Magura, and Daneyal Mahmood, and Nicole Kosanke
September 2010, The Psychiatric clinics of North America,
Andrew Rosenblum, and Jeffrey Foote, and Charles Cleland, and Stephen Magura, and Daneyal Mahmood, and Nicole Kosanke
October 2016, Journal of child psychology and psychiatry, and allied disciplines,
Andrew Rosenblum, and Jeffrey Foote, and Charles Cleland, and Stephen Magura, and Daneyal Mahmood, and Nicole Kosanke
December 2013, Behaviour research and therapy,
Andrew Rosenblum, and Jeffrey Foote, and Charles Cleland, and Stephen Magura, and Daneyal Mahmood, and Nicole Kosanke
January 2022, Rivista di psichiatria,
Andrew Rosenblum, and Jeffrey Foote, and Charles Cleland, and Stephen Magura, and Daneyal Mahmood, and Nicole Kosanke
January 2018, Behavioral sleep medicine,
Andrew Rosenblum, and Jeffrey Foote, and Charles Cleland, and Stephen Magura, and Daneyal Mahmood, and Nicole Kosanke
December 2015, Journal of consulting and clinical psychology,
Copied contents to your clipboard!